COLTENE Holding AG
COLTENE Holding AG (CLHLF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
clhlf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 4 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
COLTENE Holding AGYou CLHLF | $456M | 19.57x | — | $2.50 |
 Avacta Group Plc AVCTF | $437M | N/A | — | -$0.10 |
 BioInvent International AB (publ) BOVNF | $436M | N/A | — | -$5.05 |
 JINS HOLDINGS Inc. JNDOF | $1.1B | 9.37x | — | $356.88 |
 MedinCell S.A. MDCLF | $1.2B | N/A | — | -$0.63 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for COLTENE Holding AG (CLHLF) measures how much investors pay for each dollar of the company's trailing earnings. CLHLF's current PE ratio of 19.57x is calculated by dividing its stock price of $76.25 by its TTM earnings per share of $2.50.
Frequently asked questions
CLHLF pe ratio · 6 questionsCLHLF's current PE ratio is 19.57x as of 2026-06-09, based on a stock price of $76.25 and TTM EPS of $2.50. Data sourced from Financial Modeling Prep via CLHLF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · COLTENE Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09